Do analysts rate CRVL or CHE?

Chemed has a consensus price target of $501.50, indicating a potential upside of 17.61%. Given Chemed's stronger consensus rating and higher possible upside, analysts clearly believe Chemed is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Chemed 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has preferable valuation and earnings, CRVL or CHE?

Chemed has higher revenue and earnings than CorVel. Chemed is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.27 $110.34M $2.14 28.86 Chemed $2.53B 2.24 $265.24M $18.35 23.24

Is CRVL or CHE more profitable?

CorVel has a net margin of 11.51% compared to Chemed's net margin of 10.23%. CorVel's return on equity of 29.92% beat Chemed's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.51% 29.92% 17.68% Chemed 10.23% 27.18% 17.38%

Does the media favor CRVL or CHE?

In the previous week, CorVel had 3 more articles in the media than Chemed. MarketBeat recorded 4 mentions for CorVel and 1 mentions for Chemed. Chemed's average media sentiment score of 0.49 beat CorVel's score of 0.36 indicating that Chemed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Chemed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate MD or CRVL?

Pediatrix Medical Group currently has a consensus price target of $22.50, suggesting a potential upside of 4.46%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Pediatrix Medical Group is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, MD or CRVL?

Pediatrix Medical Group has higher revenue and earnings than CorVel. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pediatrix Medical Group $1.91B 0.92 $165.39M $2.06 10.46 CorVel $958.53M 3.27 $110.34M $2.14 28.86

Does the media prefer MD or CRVL?

In the previous week, CorVel had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 4 mentions for CorVel and 2 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.47 beat CorVel's score of 0.36 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CorVel 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend CRVL or AMN?

AMN Healthcare Services has a consensus price target of $25.29, indicating a potential downside of 13.09%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AMN Healthcare Services 2 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.22

Does the media favor CRVL or AMN?

In the previous week, AMN Healthcare Services had 8 more articles in the media than CorVel. MarketBeat recorded 12 mentions for AMN Healthcare Services and 4 mentions for CorVel. CorVel's average media sentiment score of 0.36 beat AMN Healthcare Services' score of 0.22 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CRVL or CCRN?

Cross Country Healthcare has a consensus target price of $12.72, indicating a potential downside of 2.83%. Given Cross Country Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cross Country Healthcare 1 Sell rating(s) 9 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.90

Does the media prefer CRVL or CCRN?

In the previous week, CorVel had 2 more articles in the media than Cross Country Healthcare. MarketBeat recorded 4 mentions for CorVel and 2 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.94 beat CorVel's score of 0.36 indicating that Cross Country Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cross Country Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate DGX or CRVL?

Quest Diagnostics currently has a consensus price target of $216.58, suggesting a potential upside of 11.19%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Quest Diagnostics is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.50 CorVel 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, DGX or CRVL?

Quest Diagnostics has higher revenue and earnings than CorVel. Quest Diagnostics is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quest Diagnostics $11.04B 1.95 $992M $9.05 21.52 CorVel $958.53M 3.27 $110.34M $2.14 28.86

Is DGX or CRVL more profitable?

CorVel has a net margin of 11.51% compared to Quest Diagnostics' net margin of 9.07%. CorVel's return on equity of 29.92% beat Quest Diagnostics' return on equity. Company Net Margins Return on Equity Return on Assets Quest Diagnostics 9.07% 15.60% 7.06% CorVel 11.51% 29.92% 17.68%

Does the media refer more to DGX or CRVL?

In the previous week, Quest Diagnostics had 4 more articles in the media than CorVel. MarketBeat recorded 8 mentions for Quest Diagnostics and 4 mentions for CorVel. Quest Diagnostics' average media sentiment score of 1.05 beat CorVel's score of 0.36 indicating that Quest Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quest Diagnostics 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CorVel (CRVL) Competitors

$61.75 0.00 (0.00%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$61.76 +0.01 (+0.02%)

As of 05/29/2026 05:40 PM Eastern

Compare

CRVL vs. CHE, MD, AMN, CCRN, and DGX

Should you buy CorVel stock or one of its competitors? MarketBeat compares CorVel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CorVel include Chemed (CHE), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), and Quest Diagnostics (DGX). These companies are all part of the "health care services" industry.

How does CorVel compare to Chemed?

CorVel (NASDAQ:CRVL) and Chemed (NYSE:CHE) are both mid-cap health care services companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation.

Chemed has a consensus price target of $501.50, indicating a potential upside of 17.61%. Given Chemed's stronger consensus rating and higher possible upside, analysts clearly believe Chemed is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

51.4% of CorVel shares are held by institutional investors. Comparatively, 95.9% of Chemed shares are held by institutional investors. 44.6% of CorVel shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

CorVel has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, Chemed has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market.

In the previous week, CorVel had 3 more articles in the media than Chemed. MarketBeat recorded 4 mentions for CorVel and 1 mentions for Chemed. Chemed's average media sentiment score of 0.49 beat CorVel's score of 0.36 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CorVel has a net margin of 11.51% compared to Chemed's net margin of 10.23%. CorVel's return on equity of 29.92% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
Chemed	10.23%	27.18%	17.38%

Chemed has higher revenue and earnings than CorVel. Chemed is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.27	$110.34M	$2.14	28.86
Chemed	$2.53B	2.24	$265.24M	$18.35	23.24

Summary

CorVel and Chemed tied by winning 8 of the 16 factors compared between the two stocks.

How does CorVel compare to Pediatrix Medical Group?

Pediatrix Medical Group (NYSE:MD) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, media sentiment, valuation and earnings.

Pediatrix Medical Group currently has a consensus price target of $22.50, suggesting a potential upside of 4.46%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Pediatrix Medical Group is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

97.7% of Pediatrix Medical Group shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by company insiders. Comparatively, 44.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Pediatrix Medical Group has higher revenue and earnings than CorVel. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	0.92	$165.39M	$2.06	10.46
CorVel	$958.53M	3.27	$110.34M	$2.14	28.86

In the previous week, CorVel had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 4 mentions for CorVel and 2 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 0.47 beat CorVel's score of 0.36 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pediatrix Medical Group has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, CorVel has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

CorVel has a net margin of 11.51% compared to Pediatrix Medical Group's net margin of 9.02%. CorVel's return on equity of 29.92% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	9.02%	19.94%	8.02%
CorVel	11.51%	29.92%	17.68%

Summary

CorVel beats Pediatrix Medical Group on 9 of the 16 factors compared between the two stocks.

How does CorVel compare to AMN Healthcare Services?

CorVel (NASDAQ:CRVL) and AMN Healthcare Services (NYSE:AMN) are both health care services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

CorVel has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.44, meaning that its stock price is 56% less volatile than the broader market.

CorVel has a net margin of 11.51% compared to AMN Healthcare Services' net margin of -0.95%. CorVel's return on equity of 29.92% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
AMN Healthcare Services	-0.95%	18.01%	5.19%

AMN Healthcare Services has a consensus price target of $25.29, indicating a potential downside of 13.09%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

CorVel has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.27	$110.34M	$2.14	28.86
AMN Healthcare Services	$2.73B	0.41	-$95.70M	-$0.87	N/A

51.4% of CorVel shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 44.6% of CorVel shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, AMN Healthcare Services had 8 more articles in the media than CorVel. MarketBeat recorded 12 mentions for AMN Healthcare Services and 4 mentions for CorVel. CorVel's average media sentiment score of 0.36 beat AMN Healthcare Services' score of 0.22 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

CorVel beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

How does CorVel compare to Cross Country Healthcare?

CorVel (NASDAQ:CRVL) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

CorVel has a net margin of 11.51% compared to Cross Country Healthcare's net margin of -9.84%. CorVel's return on equity of 29.92% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.51%	29.92%	17.68%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

In the previous week, CorVel had 2 more articles in the media than Cross Country Healthcare. MarketBeat recorded 4 mentions for CorVel and 2 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.94 beat CorVel's score of 0.36 indicating that Cross Country Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cross Country Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CorVel has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

CorVel has higher earnings, but lower revenue than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.27	$110.34M	$2.14	28.86
Cross Country Healthcare	$1.05B	0.40	-$94.85M	-$3.05	N/A

51.4% of CorVel shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 44.6% of CorVel shares are owned by insiders. Comparatively, 6.3% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cross Country Healthcare has a consensus target price of $12.72, indicating a potential downside of 2.83%. Given Cross Country Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Summary

CorVel beats Cross Country Healthcare on 10 of the 15 factors compared between the two stocks.

How does CorVel compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and CorVel (NASDAQ:CRVL) are both health care services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

Quest Diagnostics has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, CorVel has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 0.9% of Quest Diagnostics shares are held by company insiders. Comparatively, 44.6% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Quest Diagnostics has higher revenue and earnings than CorVel. Quest Diagnostics is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quest Diagnostics	$11.04B	1.95	$992M	$9.05	21.52
CorVel	$958.53M	3.27	$110.34M	$2.14	28.86

In the previous week, Quest Diagnostics had 4 more articles in the media than CorVel. MarketBeat recorded 8 mentions for Quest Diagnostics and 4 mentions for CorVel. Quest Diagnostics' average media sentiment score of 1.05 beat CorVel's score of 0.36 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quest Diagnostics	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CorVel has a net margin of 11.51% compared to Quest Diagnostics' net margin of 9.07%. CorVel's return on equity of 29.92% beat Quest Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quest Diagnostics	9.07%	15.60%	7.06%
CorVel	11.51%	29.92%	17.68%

Quest Diagnostics currently has a consensus price target of $216.58, suggesting a potential upside of 11.19%. Given Quest Diagnostics' stronger consensus rating and higher possible upside, equities research analysts plainly believe Quest Diagnostics is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.50
CorVel	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Quest Diagnostics beats CorVel on 9 of the 16 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRVL vs. The Competition

Export

Metric	CorVel	BUSINESS SVCS Industry	Business Sector	NASDAQ Exchange
Market Cap	$3.13B	$5.47B	$6.76B	$12.57B
Dividend Yield	N/A	2.33%	3.01%	5.31%
P/E Ratio	28.86	12.26	28.68	26.27
Price / Sales	3.27	1.46	426.90	114.93
Price / Cash	22.23	11.76	23.12	37.60
Price / Book	8.01	4.91	5.94	6.86
Net Income	$110.34M	$154.98M	$205.48M	$337.26M
7 Day Performance	-1.58%	13.24%	3.73%	3.58%
1 Month Performance	N/A	N/A	-4.25%	-0.79%
1 Year Performance	-44.72%	-3.54%	41.48%	39.67%

CorVel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRVL CorVel	1.1575 of 5 stars	$61.75 flat	N/A	-44.7%	$3.13B	$958.53M	28.86	5,239	Analyst Upgrade
CHE Chemed	3.916 of 5 stars	$436.12 -0.7%	$501.50 +15.0%	-25.8%	$5.79B	$2.53B	23.77	15,811	Analyst Upgrade Gap Up
MD Pediatrix Medical Group	2.4896 of 5 stars	$21.27 +0.0%	$22.50 +5.8%	+52.2%	$1.75B	$1.91B	10.33	4,315
AMN AMN Healthcare Services	1.619 of 5 stars	$27.30 -1.3%	$25.29 -7.4%	+38.0%	$1.06B	$2.73B	N/A	2,664	Analyst Revision
CCRN Cross Country Healthcare	2.5827 of 5 stars	$13.08 +0.2%	$12.72 -2.8%	-1.0%	$422.88M	$1.05B	N/A	6,784

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRVL) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CorVel (CRVL) Competitors

CRVL vs. CHE, MD, AMN, CCRN, and DGX

How does CorVel compare to Chemed?

Summary

How does CorVel compare to Pediatrix Medical Group?

Summary

How does CorVel compare to AMN Healthcare Services?

Summary

How does CorVel compare to Cross Country Healthcare?

Summary

How does CorVel compare to Quest Diagnostics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CorVel (CRVL) Competitors

CRVL vs. CHE, MD, AMN, CCRN, and DGX

How does CorVel compare to Chemed?

Do analysts rate CRVL or CHE?

Do insiders and institutionals believe in CRVL or CHE?

Which has more risk & volatility, CRVL or CHE?

Does the media favor CRVL or CHE?

Is CRVL or CHE more profitable?

Which has preferable valuation and earnings, CRVL or CHE?

Summary

How does CorVel compare to Pediatrix Medical Group?

Do analysts rate MD or CRVL?

Do institutionals and insiders have more ownership in MD or CRVL?

Which has preferable earnings and valuation, MD or CRVL?

Does the media prefer MD or CRVL?

Which has more volatility and risk, MD or CRVL?

Is MD or CRVL more profitable?

Summary

How does CorVel compare to AMN Healthcare Services?

Which has more volatility and risk, CRVL or AMN?

Is CRVL or AMN more profitable?

Do analysts recommend CRVL or AMN?

Which has preferable earnings & valuation, CRVL or AMN?

Do insiders and institutionals believe in CRVL or AMN?

Does the media favor CRVL or AMN?

Summary

How does CorVel compare to Cross Country Healthcare?

Is CRVL or CCRN more profitable?

Does the media prefer CRVL or CCRN?

Which has more volatility and risk, CRVL or CCRN?

Which has preferable valuation and earnings, CRVL or CCRN?

Do insiders & institutionals hold more shares of CRVL or CCRN?

Do analysts prefer CRVL or CCRN?

Summary

How does CorVel compare to Quest Diagnostics?

Which has more volatility and risk, DGX or CRVL?

Do insiders & institutionals hold more shares of DGX or CRVL?

Which has higher valuation and earnings, DGX or CRVL?

Does the media refer more to DGX or CRVL?

Is DGX or CRVL more profitable?

Do analysts rate DGX or CRVL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRVL vs. The Competition

CorVel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools